In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients

被引:182
作者
See, DM [1 ]
Broumand, N [1 ]
Sahl, L [1 ]
Tilles, JG [1 ]
机构
[1] UNIV CALIF IRVINE, IRVINE MED CTR, DEPT MED, DIV INFECT DIS, ORANGE, CA 92668 USA
来源
IMMUNOPHARMACOLOGY | 1997年 / 35卷 / 03期
关键词
ginseng; echinacea; natural killer cells; chronic fatigue syndrome; acquired immunodeficiency syndrome; EPSTEIN-BARR-VIRUS; HUMAN HERPESVIRUS-6; PANAX-GINSENG; HIV-INFECTION; PURPUREA; EXTRACTS; CULTURES; THERAPY; MICE;
D O I
10.1016/S0162-3109(96)00125-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Extracts of Echinacea purpurea and Panax ginseng were evaluated for their capacity to stimulate cellular immune function by peripheral blood mononuclear cells (PBMC) from normal individuals and patients with either the chronic fatigue syndrome or the acquired immunodeficiency syndrome. PBMC isolated on a Ficoll-hypaque density gradient were tested in the presence or absence of varying concentrations of each extract for natural killer (NK) cell activity versus K562 cells and antibody-dependent cellular cytotoxicity (ADCC) against human herpesvirus 6 infected H9 cells. Both echinacea and ginseng, at concentrations greater than or equal to 0.1 or 10 mu g/kg, respectively, significantly enhanced NK-function of all groups. Similarly, the addition of either herb significantly increased ADCC of PBMC from all subject groups. Thus, extracts of Echinacea purpurea and Panax ginseng enhance cellular immune function of PBMC both from normal individuals and patients with depressed cellular immunity.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 29 条
[1]   UTILIZATION OF HUMAN HEMATOPOIETIC-CELL LINES FOR THE PROPAGATION AND CHARACTERIZATION OF HBLV (HUMAN HERPESVIRUS-6) [J].
ABLASHI, DV ;
LUSSO, P ;
HUNG, CL ;
SALAHUDDIN, SZ ;
JOSEPHS, SF ;
LLANA, T ;
KRAMARSKY, B ;
BIBERFELD, P ;
MARKHAM, PD ;
GALLO, RC .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :787-791
[2]   INTERFERON-ALPHA THERAPY FOR PATIENTS WITH CHRONIC FATIGUE SYNDROME [J].
BROOK, MG ;
BANNISTER, BA ;
WEIR, WRC .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03) :791-792
[3]  
CAI Q, 1990, J ACQ IMMUN DEF SYND, V3, P669
[4]   FUNCTIONAL ACTIVITIES OF 20 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC HUMAN MONOCLONAL-ANTIBODIES [J].
FORTHAL, DN ;
LANDUCCI, G ;
GORNY, MK ;
ZOLLAPAZNER, S ;
ROBINSON, WE .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (09) :1095-1099
[5]   A COMPREHENSIVE IMMUNOLOGICAL ANALYSIS IN CHRONIC FATIGUE SYNDROME [J].
GUPTA, S ;
VAYUVEGULA, B .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 33 (03) :319-327
[6]  
Hobbs C., 1989, The Echinacea Handbook
[7]   CHRONIC FATIGUE SYNDROME - A WORKING CASE DEFINITION [J].
HOLMES, GP ;
KAPLAN, JE ;
GANTZ, NM ;
KOMAROFF, AL ;
SCHONBERGER, LB ;
STRAUS, SE ;
JONES, JF ;
DUBOIS, RE ;
CUNNINGHAMRUNDLES, C ;
PAHWA, S ;
TOSATO, G ;
ZEGANS, LS ;
PURTILO, DT ;
BROWN, N ;
SCHOOLEY, RT ;
BRUS, I .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) :387-389
[8]   NATURAL-KILLER CYTOTOXICITY AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS BY LEUKOCYTES FROM HUMAN NEONATES AND ADULTS [J].
JENKINS, M ;
MILLS, J ;
KOHL, S .
PEDIATRIC RESEARCH, 1993, 33 (05) :469-474
[9]   IMMUNE FUNCTION IN CHRONIC ACTIVE EPSTEIN-BARR VIRUS-INFECTION [J].
KIBLER, R ;
LUCAS, DO ;
HICKS, MJ ;
POULOS, BT ;
JONES, JF .
JOURNAL OF CLINICAL IMMUNOLOGY, 1985, 5 (01) :46-54
[10]   INTERFERON INDUCTION BY HUMAN HERPESVIRUS-6 IN HUMAN MONONUCLEAR-CELLS [J].
KIKUTA, H ;
NAKANE, A ;
LU, H ;
TAGUCHI, Y ;
MINAGAWA, T ;
MATSUMOTO, S .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :35-38